𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells

✍ Scribed by Hongyan Gu; Shuyun Rao; Jie Zhao; Jia Wang; Rong Mu; Jingjing Rong; Lei Tao; Qi Qi; Qidong You; Qinglong Guo


Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
413 KB
Volume
135
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


bcl-2 over-expression enhances NF-ΞΊB act
✍ Alfredo Ricca; Annamaria Biroccio; Donatella Del Bufalo; Andrew R. Mackay; Angel πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 204 KB πŸ‘ 1 views

bcl-2 expression is often associated with poor prognosis in several types of tumors; however, the role of this molecule in breast cancer is still controversial. We found earlier that over-expression of bcl-2 in a human breast-cancer cell line (MCF7 ADR ) enhances its tumorigenicity and metastatic po

Induction of wild-type p53, Bax, and aci
✍ Kamal Sharma; Coimbatore B. Srikant πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 202 KB πŸ‘ 1 views

Somatostatin (SST) analogs inhibit tumor cell growth by exerting direct anti-proliferative effects with cytostatic (growth arrest) or cytotoxic (apoptosis) consequences. The SST analog SMS 201-995 (octreotide, OCT) inhibits growth of MCF-7 human breast adenocarcinoma cells, which express multiple SS

Roscovitine-activated HIP2 kinase induce
✍ JΓ³zefa WΔ™sierska-GΔ…dek; M. Lienhard Schmitz; Carmen Ranftler πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 314 KB

## Abstract Human MCF‐7 breast cancer cells are relatively resistant to conventional chemotherapy due to the lack of caspase‐3 activity. We reported recently that roscovitine (ROSC), a potent cyclin‐dependent kinase 2 inhibitor, arrests human MCF‐7 breast cancer cells in the G~2~ phase of the cell